Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,933,900
-$2,012,700 QoQ
Shares Held
470,000
-28.8% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#58
of 323 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Jun 30, 2026CallValue
$4,603,500
CallShares
550,000
PutValue
$8,370,000
PutShares
1,000,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. ADMA ranks #16 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in ADMA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,933,900 | 470,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $8,370,000 | 1,000,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $4,603,500 | 550,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $5,946,600 | 660,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $10,347,084 | 1,148,400 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $13,742,953 | 1,525,300 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $5,700,000 | 312,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $912,000 | 50,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $4,361,350 | 297,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $4,874,450 | 332,500 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $2,858,700 | 195,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,329,796 | 347,600 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $5,417,475 | 297,500 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $1,966,680 | 108,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,882,496 | 346,900 | Call | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||